Atul Pande
CIK 1643071 · last filed 2026-08-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.52M
Companies
5
Total Filings
58
Lifetime Open-Market Net
-$8.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMVT | Director | 138,231 | $39.90 | $5.52M | -$1.01M | 16 | 2026-08-28 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | -$7.50M | 26 | 2024-03-18 |
| Sio Gene Therapies Inc. (SIOX) Delisted | Director | 33,370 | $0.48 | $16.0K | $23.4K | 2 | 2021-04-19 |
| Sio Gene Therapies Inc. (AXGT) Delisted | Director | 26,740 | — | — | $62.7K | 4 | 2020-07-10 |
| Immunovant, Inc. (IMVTW) Delisted | Director | 24,700 | — | — | $0 | 2 | 2020-05-18 |
Recent Filings · Page 4 of 6
58 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-23 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-01 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$238.6K | EDGAR |
| 2021-05-03 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$496.6K | EDGAR |
| 2021-04-19 | Sio Gene Therapies Inc. (SIOX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-23 | IMVT | Grant (A) | +15,500 | $0 | EDGAR |
| 2021-03-03 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$273.6K | EDGAR |
| 2021-02-01 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$210.0K | EDGAR |
| 2020-12-14 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$512.7K | EDGAR |
| 2020-11-25 | Sio Gene Therapies Inc. (SIOX) Delisted | Buy (P) | +10,000 | $23.4K | EDGAR |
| 2020-11-12 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$469.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.